1 Scope of the Report 1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 1.8 Market Estimation Caveats 2 Executive Summary 2.1 World Market Overview 2.1.1 Global Human iPSCs Market Size 2018-2029 2.1.2 Human iPSCs Market Size CAGR by Region 2018 VS 2022 VS 2029 2.2 Human iPSCs Segment by Type 2.2.1 Skin 2.2.2 Blood Cells 2.3 Human iPSCs Market Size by Type 2.3.1 Human iPSCs Market Size CAGR by Type (2018 VS 2022 VS 2029) 2.3.2 Global Human iPSCs Market Size Market Share by Type (2018-2023) 2.4 Human iPSCs Segment by Application 2.4.1 Academic Research 2.4.2 Drug Development and Discovery 2.4.3 Toxicity Screening 2.4.4 Regenerative Medicine 2.4.5 Others 2.5 Human iPSCs Market Size by Application 2.5.1 Human iPSCs Market Size CAGR by Application (2018 VS 2022 VS 2029) 2.5.2 Global Human iPSCs Market Size Market Share by Application (2018-2023) 3 Human iPSCs Market Size by Player 3.1 Human iPSCs Market Size Market Share by Players 3.1.1 Global Human iPSCs Revenue by Players (2018-2023) 3.1.2 Global Human iPSCs Revenue Market Share by Players (2018-2023) 3.2 Global Human iPSCs Key Players Head office and Products Offered 3.3 Market Concentration Rate Analysis 3.3.1 Competition Landscape Analysis 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023) 3.4 New Products and Potential Entrants 3.5 Mergers & Acquisitions, Expansion 4 Human iPSCs by Regions 4.1 Human iPSCs Market Size by Regions (2018-2023) 4.2 Americas Human iPSCs Market Size Growth (2018-2023) 4.3 APAC Human iPSCs Market Size Growth (2018-2023) 4.4 Europe Human iPSCs Market Size Growth (2018-2023) 4.5 Middle East & Africa Human iPSCs Market Size Growth (2018-2023) 5 Americas 5.1 Americas Human iPSCs Market Size by Country (2018-2023) 5.2 Americas Human iPSCs Market Size by Type (2018-2023) 5.3 Americas Human iPSCs Market Size by Application (2018-2023) 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC Human iPSCs Market Size by Region (2018-2023) 6.2 APAC Human iPSCs Market Size by Type (2018-2023) 6.3 APAC Human iPSCs Market Size by Application (2018-2023) 6.4 China 6.5 Japan 6.6 Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 7 Europe 7.1 Europe Human iPSCs by Country (2018-2023) 7.2 Europe Human iPSCs Market Size by Type (2018-2023) 7.3 Europe Human iPSCs Market Size by Application (2018-2023) 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa Human iPSCs by Region (2018-2023) 8.2 Middle East & Africa Human iPSCs Market Size by Type (2018-2023) 8.3 Middle East & Africa Human iPSCs Market Size by Application (2018-2023) 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Countries 9 Market Drivers, Challenges and Trends 9.1 Market Drivers & Growth Opportunities 9.2 Market Challenges & Risks 9.3 Industry Trends 10 Global Human iPSCs Market Forecast 10.1 Global Human iPSCs Forecast by Regions (2024-2029) 10.1.1 Global Human iPSCs Forecast by Regions (2024-2029) 10.1.2 Americas Human iPSCs Forecast 10.1.3 APAC Human iPSCs Forecast 10.1.4 Europe Human iPSCs Forecast 10.1.5 Middle East & Africa Human iPSCs Forecast 10.2 Americas Human iPSCs Forecast by Country (2024-2029) 10.2.1 United States Human iPSCs Market Forecast 10.2.2 Canada Human iPSCs Market Forecast 10.2.3 Mexico Human iPSCs Market Forecast 10.2.4 Brazil Human iPSCs Market Forecast 10.3 APAC Human iPSCs Forecast by Region (2024-2029) 10.3.1 China Human iPSCs Market Forecast 10.3.2 Japan Human iPSCs Market Forecast 10.3.3 Korea Human iPSCs Market Forecast 10.3.4 Southeast Asia Human iPSCs Market Forecast 10.3.5 India Human iPSCs Market Forecast 10.3.6 Australia Human iPSCs Market Forecast 10.4 Europe Human iPSCs Forecast by Country (2024-2029) 10.4.1 Germany Human iPSCs Market Forecast 10.4.2 France Human iPSCs Market Forecast 10.4.3 UK Human iPSCs Market Forecast 10.4.4 Italy Human iPSCs Market Forecast 10.4.5 Russia Human iPSCs Market Forecast 10.5 Middle East & Africa Human iPSCs Forecast by Region (2024-2029) 10.5.1 Egypt Human iPSCs Market Forecast 10.5.2 South Africa Human iPSCs Market Forecast 10.5.3 Israel Human iPSCs Market Forecast 10.5.4 Turkey Human iPSCs Market Forecast 10.5.5 GCC Countries Human iPSCs Market Forecast 10.6 Global Human iPSCs Forecast by Type (2024-2029) 10.7 Global Human iPSCs Forecast by Application (2024-2029) 11 Key Players Analysis 11.1 Fujifilm Holding Corporation (CDI) 11.1.1 Fujifilm Holding Corporation (CDI) Company Information 11.1.2 Fujifilm Holding Corporation (CDI) Human iPSCs Product Offered 11.1.3 Fujifilm Holding Corporation (CDI) Human iPSCs Revenue, Gross Margin and Market Share (2018-2023) 11.1.4 Fujifilm Holding Corporation (CDI) Main Business Overview 11.1.5 Fujifilm Holding Corporation (CDI) Latest Developments 11.2 Ncardia 11.2.1 Ncardia Company Information 11.2.2 Ncardia Human iPSCs Product Offered 11.2.3 Ncardia Human iPSCs Revenue, Gross Margin and Market Share (2018-2023) 11.2.4 Ncardia Main Business Overview 11.2.5 Ncardia Latest Developments 11.3 Sumitomo Dainippon Pharma 11.3.1 Sumitomo Dainippon Pharma Company Information 11.3.2 Sumitomo Dainippon Pharma Human iPSCs Product Offered 11.3.3 Sumitomo Dainippon Pharma Human iPSCs Revenue, Gross Margin and Market Share (2018-2023) 11.3.4 Sumitomo Dainippon Pharma Main Business Overview 11.3.5 Sumitomo Dainippon Pharma Latest Developments 11.4 Astellas Pharma Inc 11.4.1 Astellas Pharma Inc Company Information 11.4.2 Astellas Pharma Inc Human iPSCs Product Offered 11.4.3 Astellas Pharma Inc Human iPSCs Revenue, Gross Margin and Market Share (2018-2023) 11.4.4 Astellas Pharma Inc Main Business Overview 11.4.5 Astellas Pharma Inc Latest Developments 11.5 Fate Therapeutics, Inc 11.5.1 Fate Therapeutics, Inc Company Information 11.5.2 Fate Therapeutics, Inc Human iPSCs Product Offered 11.5.3 Fate Therapeutics, Inc Human iPSCs Revenue, Gross Margin and Market Share (2018-2023) 11.5.4 Fate Therapeutics, Inc Main Business Overview 11.5.5 Fate Therapeutics, Inc Latest Developments 11.6 Pluricell Biotech 11.6.1 Pluricell Biotech Company Information 11.6.2 Pluricell Biotech Human iPSCs Product Offered 11.6.3 Pluricell Biotech Human iPSCs Revenue, Gross Margin and Market Share (2018-2023) 11.6.4 Pluricell Biotech Main Business Overview 11.6.5 Pluricell Biotech Latest Developments 11.7 Cell Inspire Biotechnology 11.7.1 Cell Inspire Biotechnology Company Information 11.7.2 Cell Inspire Biotechnology Human iPSCs Product Offered 11.7.3 Cell Inspire Biotechnology Human iPSCs Revenue, Gross Margin and Market Share (2018-2023) 11.7.4 Cell Inspire Biotechnology Main Business Overview 11.7.5 Cell Inspire Biotechnology Latest Developments 11.8 ReproCELL 11.8.1 ReproCELL Company Information 11.8.2 ReproCELL Human iPSCs Product Offered 11.8.3 ReproCELL Human iPSCs Revenue, Gross Margin and Market Share (2018-2023) 11.8.4 ReproCELL Main Business Overview 11.8.5 ReproCELL Latest Developments 12 Research Findings and Conclusion

List of Tables Table 1. Human iPSCs Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions) Table 2. Major Players of Skin Table 3. Major Players of Blood Cells Table 4. Human iPSCs Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions) Table 5. Global Human iPSCs Market Size by Type (2018-2023) & ($ Millions) Table 6. Global Human iPSCs Market Size Market Share by Type (2018-2023) Table 7. Human iPSCs Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions) Table 8. Global Human iPSCs Market Size by Application (2018-2023) & ($ Millions) Table 9. Global Human iPSCs Market Size Market Share by Application (2018-2023) Table 10. Global Human iPSCs Revenue by Players (2018-2023) & ($ Millions) Table 11. Global Human iPSCs Revenue Market Share by Player (2018-2023) Table 12. Human iPSCs Key Players Head office and Products Offered Table 13. Human iPSCs Concentration Ratio (CR3, CR5 and CR10) & (2021-2023) Table 14. New Products and Potential Entrants Table 15. Mergers & Acquisitions, Expansion Table 16. Global Human iPSCs Market Size by Regions 2018-2023 & ($ Millions) Table 17. Global Human iPSCs Market Size Market Share by Regions (2018-2023) Table 18. Global Human iPSCs Revenue by Country/Region (2018-2023) & ($ millions) Table 19. Global Human iPSCs Revenue Market Share by Country/Region (2018-2023) Table 20. Americas Human iPSCs Market Size by Country (2018-2023) & ($ Millions) Table 21. Americas Human iPSCs Market Size Market Share by Country (2018-2023) Table 22. Americas Human iPSCs Market Size by Type (2018-2023) & ($ Millions) Table 23. Americas Human iPSCs Market Size Market Share by Type (2018-2023) Table 24. Americas Human iPSCs Market Size by Application (2018-2023) & ($ Millions) Table 25. Americas Human iPSCs Market Size Market Share by Application (2018-2023) Table 26. APAC Human iPSCs Market Size by Region (2018-2023) & ($ Millions) Table 27. APAC Human iPSCs Market Size Market Share by Region (2018-2023) Table 28. APAC Human iPSCs Market Size by Type (2018-2023) & ($ Millions) Table 29. APAC Human iPSCs Market Size Market Share by Type (2018-2023) Table 30. APAC Human iPSCs Market Size by Application (2018-2023) & ($ Millions) Table 31. APAC Human iPSCs Market Size Market Share by Application (2018-2023) Table 32. Europe Human iPSCs Market Size by Country (2018-2023) & ($ Millions) Table 33. Europe Human iPSCs Market Size Market Share by Country (2018-2023) Table 34. Europe Human iPSCs Market Size by Type (2018-2023) & ($ Millions) Table 35. Europe Human iPSCs Market Size Market Share by Type (2018-2023) Table 36. Europe Human iPSCs Market Size by Application (2018-2023) & ($ Millions) Table 37. Europe Human iPSCs Market Size Market Share by Application (2018-2023) Table 38. Middle East & Africa Human iPSCs Market Size by Region (2018-2023) & ($ Millions) Table 39. Middle East & Africa Human iPSCs Market Size Market Share by Region (2018-2023) Table 40. Middle East & Africa Human iPSCs Market Size by Type (2018-2023) & ($ Millions) Table 41. Middle East & Africa Human iPSCs Market Size Market Share by Type (2018-2023) Table 42. Middle East & Africa Human iPSCs Market Size by Application (2018-2023) & ($ Millions) Table 43. Middle East & Africa Human iPSCs Market Size Market Share by Application (2018-2023) Table 44. Key Market Drivers & Growth Opportunities of Human iPSCs Table 45. Key Market Challenges & Risks of Human iPSCs Table 46. Key Industry Trends of Human iPSCs Table 47. Global Human iPSCs Market Size Forecast by Regions (2024-2029) & ($ Millions) Table 48. Global Human iPSCs Market Size Market Share Forecast by Regions (2024-2029) Table 49. Global Human iPSCs Market Size Forecast by Type (2024-2029) & ($ Millions) Table 50. Global Human iPSCs Market Size Forecast by Application (2024-2029) & ($ Millions) Table 51. Fujifilm Holding Corporation (CDI) Details, Company Type, Human iPSCs Area Served and Its Competitors Table 52. Fujifilm Holding Corporation (CDI) Human iPSCs Product Offered Table 53. Fujifilm Holding Corporation (CDI) Human iPSCs Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 54. Fujifilm Holding Corporation (CDI) Main Business Table 55. Fujifilm Holding Corporation (CDI) Latest Developments Table 56. Ncardia Details, Company Type, Human iPSCs Area Served and Its Competitors Table 57. Ncardia Human iPSCs Product Offered Table 58. Ncardia Main Business Table 59. Ncardia Human iPSCs Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 60. Ncardia Latest Developments Table 61. Sumitomo Dainippon Pharma Details, Company Type, Human iPSCs Area Served and Its Competitors Table 62. Sumitomo Dainippon Pharma Human iPSCs Product Offered Table 63. Sumitomo Dainippon Pharma Main Business Table 64. Sumitomo Dainippon Pharma Human iPSCs Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 65. Sumitomo Dainippon Pharma Latest Developments Table 66. Astellas Pharma Inc Details, Company Type, Human iPSCs Area Served and Its Competitors Table 67. Astellas Pharma Inc Human iPSCs Product Offered Table 68. Astellas Pharma Inc Main Business Table 69. Astellas Pharma Inc Human iPSCs Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 70. Astellas Pharma Inc Latest Developments Table 71. Fate Therapeutics, Inc Details, Company Type, Human iPSCs Area Served and Its Competitors Table 72. Fate Therapeutics, Inc Human iPSCs Product Offered Table 73. Fate Therapeutics, Inc Main Business Table 74. Fate Therapeutics, Inc Human iPSCs Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 75. Fate Therapeutics, Inc Latest Developments Table 76. Pluricell Biotech Details, Company Type, Human iPSCs Area Served and Its Competitors Table 77. Pluricell Biotech Human iPSCs Product Offered Table 78. Pluricell Biotech Main Business Table 79. Pluricell Biotech Human iPSCs Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 80. Pluricell Biotech Latest Developments Table 81. Cell Inspire Biotechnology Details, Company Type, Human iPSCs Area Served and Its Competitors Table 82. Cell Inspire Biotechnology Human iPSCs Product Offered Table 83. Cell Inspire Biotechnology Main Business Table 84. Cell Inspire Biotechnology Human iPSCs Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 85. Cell Inspire Biotechnology Latest Developments Table 86. ReproCELL Details, Company Type, Human iPSCs Area Served and Its Competitors Table 87. ReproCELL Human iPSCs Product Offered Table 88. ReproCELL Main Business Table 89. ReproCELL Human iPSCs Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 90. ReproCELL Latest Developments List of Figures Figure 1. Human iPSCs Report Years Considered Figure 2. Research Objectives Figure 3. Research Methodology Figure 4. Research Process and Data Source Figure 5. Global Human iPSCs Market Size Growth Rate 2018-2029 ($ Millions) Figure 6. Human iPSCs Sales by Geographic Region (2018, 2022 & 2029) & ($ millions) Figure 7. Human iPSCs Sales Market Share by Country/Region (2022) Figure 8. Human iPSCs Sales Market Share by Country/Region (2018, 2022 & 2029) Figure 9. Global Human iPSCs Market Size Market Share by Type in 2022 Figure 10. Human iPSCs in Academic Research Figure 11. Global Human iPSCs Market: Academic Research (2018-2023) & ($ Millions) Figure 12. Human iPSCs in Drug Development and Discovery Figure 13. Global Human iPSCs Market: Drug Development and Discovery (2018-2023) & ($ Millions) Figure 14. Human iPSCs in Toxicity Screening Figure 15. Global Human iPSCs Market: Toxicity Screening (2018-2023) & ($ Millions) Figure 16. Human iPSCs in Regenerative Medicine Figure 17. Global Human iPSCs Market: Regenerative Medicine (2018-2023) & ($ Millions) Figure 18. Human iPSCs in Others Figure 19. Global Human iPSCs Market: Others (2018-2023) & ($ Millions) Figure 20. Global Human iPSCs Market Size Market Share by Application in 2022 Figure 21. Global Human iPSCs Revenue Market Share by Player in 2022 Figure 22. Global Human iPSCs Market Size Market Share by Regions (2018-2023) Figure 23. Americas Human iPSCs Market Size 2018-2023 ($ Millions) Figure 24. APAC Human iPSCs Market Size 2018-2023 ($ Millions) Figure 25. Europe Human iPSCs Market Size 2018-2023 ($ Millions) Figure 26. Middle East & Africa Human iPSCs Market Size 2018-2023 ($ Millions) Figure 27. Americas Human iPSCs Value Market Share by Country in 2022 Figure 28. United States Human iPSCs Market Size Growth 2018-2023 ($ Millions) Figure 29. Canada Human iPSCs Market Size Growth 2018-2023 ($ Millions) Figure 30. Mexico Human iPSCs Market Size Growth 2018-2023 ($ Millions) Figure 31. Brazil Human iPSCs Market Size Growth 2018-2023 ($ Millions) Figure 32. APAC Human iPSCs Market Size Market Share by Region in 2022 Figure 33. APAC Human iPSCs Market Size Market Share by Type in 2022 Figure 34. APAC Human iPSCs Market Size Market Share by Application in 2022 Figure 35. China Human iPSCs Market Size Growth 2018-2023 ($ Millions) Figure 36. Japan Human iPSCs Market Size Growth 2018-2023 ($ Millions) Figure 37. Korea Human iPSCs Market Size Growth 2018-2023 ($ Millions) Figure 38. Southeast Asia Human iPSCs Market Size Growth 2018-2023 ($ Millions) Figure 39. India Human iPSCs Market Size Growth 2018-2023 ($ Millions) Figure 40. Australia Human iPSCs Market Size Growth 2018-2023 ($ Millions) Figure 41. Europe Human iPSCs Market Size Market Share by Country in 2022 Figure 42. Europe Human iPSCs Market Size Market Share by Type (2018-2023) Figure 43. Europe Human iPSCs Market Size Market Share by Application (2018-2023) Figure 44. Germany Human iPSCs Market Size Growth 2018-2023 ($ Millions) Figure 45. France Human iPSCs Market Size Growth 2018-2023 ($ Millions) Figure 46. UK Human iPSCs Market Size Growth 2018-2023 ($ Millions) Figure 47. Italy Human iPSCs Market Size Growth 2018-2023 ($ Millions) Figure 48. Russia Human iPSCs Market Size Growth 2018-2023 ($ Millions) Figure 49. Middle East & Africa Human iPSCs Market Size Market Share by Region (2018-2023) Figure 50. Middle East & Africa Human iPSCs Market Size Market Share by Type (2018-2023) Figure 51. Middle East & Africa Human iPSCs Market Size Market Share by Application (2018-2023) Figure 52. Egypt Human iPSCs Market Size Growth 2018-2023 ($ Millions) Figure 53. South Africa Human iPSCs Market Size Growth 2018-2023 ($ Millions) Figure 54. Israel Human iPSCs Market Size Growth 2018-2023 ($ Millions) Figure 55. Turkey Human iPSCs Market Size Growth 2018-2023 ($ Millions) Figure 56. GCC Country Human iPSCs Market Size Growth 2018-2023 ($ Millions) Figure 57. Americas Human iPSCs Market Size 2024-2029 ($ Millions) Figure 58. APAC Human iPSCs Market Size 2024-2029 ($ Millions) Figure 59. Europe Human iPSCs Market Size 2024-2029 ($ Millions) Figure 60. Middle East & Africa Human iPSCs Market Size 2024-2029 ($ Millions) Figure 61. United States Human iPSCs Market Size 2024-2029 ($ Millions) Figure 62. Canada Human iPSCs Market Size 2024-2029 ($ Millions) Figure 63. Mexico Human iPSCs Market Size 2024-2029 ($ Millions) Figure 64. Brazil Human iPSCs Market Size 2024-2029 ($ Millions) Figure 65. China Human iPSCs Market Size 2024-2029 ($ Millions) Figure 66. Japan Human iPSCs Market Size 2024-2029 ($ Millions) Figure 67. Korea Human iPSCs Market Size 2024-2029 ($ Millions) Figure 68. Southeast Asia Human iPSCs Market Size 2024-2029 ($ Millions) Figure 69. India Human iPSCs Market Size 2024-2029 ($ Millions) Figure 70. Australia Human iPSCs Market Size 2024-2029 ($ Millions) Figure 71. Germany Human iPSCs Market Size 2024-2029 ($ Millions) Figure 72. France Human iPSCs Market Size 2024-2029 ($ Millions) Figure 73. UK Human iPSCs Market Size 2024-2029 ($ Millions) Figure 74. Italy Human iPSCs Market Size 2024-2029 ($ Millions) Figure 75. Russia Human iPSCs Market Size 2024-2029 ($ Millions) Figure 76. Spain Human iPSCs Market Size 2024-2029 ($ Millions) Figure 77. Egypt Human iPSCs Market Size 2024-2029 ($ Millions) Figure 78. South Africa Human iPSCs Market Size 2024-2029 ($ Millions) Figure 79. Israel Human iPSCs Market Size 2024-2029 ($ Millions) Figure 80. Turkey Human iPSCs Market Size 2024-2029 ($ Millions) Figure 81. GCC Countries Human iPSCs Market Size 2024-2029 ($ Millions) Figure 82. Global Human iPSCs Market Size Market Share Forecast by Type (2024-2029) Figure 83. Global Human iPSCs Market Size Market Share Forecast by Application (2024-2029)